黄斑-话题@MedSci

#黄斑#

154篇内容 | 3714人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1525173, encodeId=346815251e322, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=新发现：免疫刺激蛋白IL-4是年龄相关性黄斑变性的潜在新药靶标, objectType=article, longId=193754, objectId=a0f4193e5449, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0f4193e5449, replyNumber=0, likeNumber=98, createdTime=2020-05-10, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0f4193e5449, moduleTitle=新发现：免疫刺激蛋白IL-4是年龄相关性黄斑变性的潜在新药靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0f4193e5449)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525172, encodeId=629915251e22a, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=诺华的抗血管内皮生长因子（VEGF）单抗Beovu获欧盟批准，用于治疗年龄相关的湿性黄斑变性, objectType=article, longId=188479, objectId=2f351884e941, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f351884e941, replyNumber=0, likeNumber=112, createdTime=2020-02-22, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f351884e941, moduleTitle=诺华的抗血管内皮生长因子（VEGF）单抗Beovu获欧盟批准，用于治疗年龄相关的湿性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f351884e941)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525171, encodeId=35e115251e131, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, objectType=article, longId=187876, objectId=f10618e87660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f10618e87660, replyNumber=0, likeNumber=84, createdTime=2020-02-13, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f10618e87660, moduleTitle=KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f10618e87660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525170, encodeId=48f215251e02a, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=拜耳的Eylea在针对湿性年龄相关性黄斑变性的ALTAIR IV期研究中展现出疗效和安全性, objectType=article, longId=187857, objectId=d62e18e85710, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d62e18e85710, replyNumber=0, likeNumber=81, createdTime=2020-02-13, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d62e18e85710, moduleTitle=拜耳的Eylea在针对湿性年龄相关性黄斑变性的ALTAIR IV期研究中展现出疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d62e18e85710)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525169, encodeId=6a9f15251699d, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Cell Death Dis：抑制甲状腺激素信号通路或可用于治疗老年性黄斑变性, objectType=article, longId=187768, objectId=1a9118e7688b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a9118e7688b, replyNumber=0, likeNumber=100, createdTime=2020-02-11, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a9118e7688b, moduleTitle=Cell Death Dis：抑制甲状腺激素信号通路或可用于治疗老年性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a9118e7688b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525168, encodeId=4bcd1525168b3, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=老年黄斑变性（AMD）的治疗新思路：Nomacopan抑制补体活化，降低VEGF水平, objectType=article, longId=186921, objectId=12411869213e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12411869213e, replyNumber=0, likeNumber=58, createdTime=2020-01-30, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12411869213e, moduleTitle=老年黄斑变性（AMD）的治疗新思路：Nomacopan抑制补体活化，降低VEGF水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12411869213e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525167, encodeId=7a5b152516ed8, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=2019 AAO临床指南：年龄相关性黄斑变性, objectType=article, longId=186668, objectId=41f718666864, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41f718666864, replyNumber=0, likeNumber=44, createdTime=2020-01-24, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41f718666864, moduleTitle=2019 AAO临床指南：年龄相关性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41f718666864)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525166, encodeId=6cb41525166f0, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Gyroscope Theraputics获得5040万英镑的B轮融资，继续推进基因疗法治疗干性年龄相关性黄斑变性, objectType=article, longId=178780, objectId=f3c01e8780a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3c01e8780a4, replyNumber=0, likeNumber=62, createdTime=2019-09-05, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3c01e8780a4, moduleTitle=Gyroscope Theraputics获得5040万英镑的B轮融资，继续推进基因疗法治疗干性年龄相关性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3c01e8780a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525165, encodeId=f24615251658d, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=第37届ASRS会议：Risuteganib治疗中度干性老年黄斑变性的II期研究结果, objectType=article, longId=176181, objectId=27601e6181b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27601e6181b6, replyNumber=0, likeNumber=75, createdTime=2019-07-27, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27601e6181b6, moduleTitle=第37届ASRS会议：Risuteganib治疗中度干性老年黄斑变性的II期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27601e6181b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525164, encodeId=8fb115251647d, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Adv Ther：年龄相关的黄斑变性治疗药物转变-Bevacizumab或Ranibizumab转换为Aflibercept, objectType=article, longId=166454, objectId=6ee2166454fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ee2166454fd, replyNumber=0, likeNumber=98, createdTime=2019-05-22, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ee2166454fd, moduleTitle=Adv Ther：年龄相关的黄斑变性治疗药物转变-Bevacizumab或Ranibizumab转换为Aflibercept, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ee2166454fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525163, encodeId=e7f21525163e6, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=2019年ARVO：Aflibercept能够长期改善黄斑变性的临床症状, objectType=article, longId=165443, objectId=df6916544389, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df6916544389, replyNumber=0, likeNumber=91, createdTime=2019-05-07, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df6916544389, moduleTitle=2019年ARVO：Aflibercept能够长期改善黄斑变性的临床症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df6916544389)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525162, encodeId=0a86152516256, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Ophthalmol Ther：黄斑毛细血管扩张症2型的治疗综述, objectType=article, longId=165265, objectId=fb7a165265e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb7a165265e3, replyNumber=0, likeNumber=98, createdTime=2019-05-02, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb7a165265e3, moduleTitle=Ophthalmol Ther：黄斑毛细血管扩张症2型的治疗综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb7a165265e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525161, encodeId=8ad8152516145, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=NEJM：羟氯喹相关的牛眼黄斑病变-病例报道, objectType=article, longId=164970, objectId=777d1649e00d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=777d1649e00d, replyNumber=0, likeNumber=79, createdTime=2019-04-26, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=777d1649e00d, moduleTitle=NEJM：羟氯喹相关的牛眼黄斑病变-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=777d1649e00d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525160, encodeId=31ac152516007, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=人工智能识别出7个潜力药物，治疗老年性黄斑变性, objectType=article, longId=164434, objectId=8faf16443453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8faf16443453, replyNumber=0, likeNumber=89, createdTime=2019-04-18, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8faf16443453, moduleTitle=人工智能识别出7个潜力药物，治疗老年性黄斑变性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8faf16443453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525159, encodeId=0267152515953, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落, objectType=article, longId=163580, objectId=c57516358096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57516358096, replyNumber=0, likeNumber=0, createdTime=2019-04-05, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57516358096, moduleTitle=DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c57516358096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525158, encodeId=12a9152515864, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=罗氏和基因泰克启动3期临床试验：评价双特异性抗体faricimab在湿性老年性黄斑变性中的潜力, objectType=article, longId=162129, objectId=56b216212948, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56b216212948, replyNumber=0, likeNumber=79, createdTime=2019-03-13, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56b216212948, moduleTitle=罗氏和基因泰克启动3期临床试验：评价双特异性抗体faricimab在湿性老年性黄斑变性中的潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56b216212948)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525157, encodeId=afff152515ef8, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Clin Exp Optom：新生血管年龄相关性黄斑变性患者眼内阿米替普治疗及其对脉络膜厚度的影响, objectType=article, longId=161454, objectId=bba5161454b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bba5161454b9, replyNumber=0, likeNumber=75, createdTime=2019-03-02, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bba5161454b9, moduleTitle=Clin Exp Optom：新生血管年龄相关性黄斑变性患者眼内阿米替普治疗及其对脉络膜厚度的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bba5161454b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525156, encodeId=66cc1525156a5, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=Klin Monbl Augenheilkd：阿柏西普对视网膜中央静脉阻塞后黄斑水肿的治疗效果, objectType=article, longId=161126, objectId=f754161126ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f754161126ef, replyNumber=0, likeNumber=62, createdTime=2019-02-27, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f754161126ef, moduleTitle=Klin Monbl Augenheilkd：阿柏西普对视网膜中央静脉阻塞后黄斑水肿的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f754161126ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525155, encodeId=c17c152515511, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=英国医生开创基因疗法治疗老年性黄斑病变, objectType=article, longId=160933, objectId=ac9b16093344, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac9b16093344, replyNumber=0, likeNumber=78, createdTime=2019-02-25, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac9b16093344, moduleTitle=英国医生开创基因疗法治疗老年性黄斑病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac9b16093344)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1525154, encodeId=76d0152515479, content=<a href='/topic/show?id=65e91031337f' target=_blank style='color:#2F92EE;'>#黄斑#</a>, objectTitle=英国实施全球首例老年黄斑变性基因疗法手术, objectType=article, longId=160870, objectId=7e701608e08d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e701608e08d, replyNumber=0, likeNumber=81, createdTime=2019-02-24, rootId=0, userName=muzishouyi, userId=638b11619344, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e701608e08d, moduleTitle=英国实施全球首例老年黄斑变性基因疗法手术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e701608e08d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

黄斑

2020-05-29

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

新发现：免疫刺激蛋白IL-4是年龄相关性黄斑变性的潜在新药靶标

2020-05-10

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

诺华的抗血管内皮生长因子（VEGF）单抗Beovu获欧盟批准，用于治疗年龄相关的湿性黄斑变性

2020-02-22

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

KSI-301治疗湿性AMD、糖尿病性黄斑水肿和视网膜静脉阻塞的Ib期临床试验取得积极结果

2020-02-13

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

拜耳的Eylea在针对湿性年龄相关性黄斑变性的ALTAIR IV期研究中展现出疗效和安全性

2020-02-13

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Cell Death Dis：抑制甲状腺激素信号通路或可用于治疗老年性黄斑变性

2020-02-11

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

老年黄斑变性（AMD）的治疗新思路：Nomacopan抑制补体活化，降低VEGF水平

2020-01-30

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

2019 AAO临床指南：年龄相关性黄斑变性

2020-01-24

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Gyroscope Theraputics获得5040万英镑的B轮融资，继续推进基因疗法治疗干性年龄相关性黄斑变性

2019-09-05

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

第37届ASRS会议：Risuteganib治疗中度干性老年黄斑变性的II期研究结果

2019-07-27

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Adv Ther：年龄相关的黄斑变性治疗药物转变-Bevacizumab或Ranibizumab转换为Aflibercept

2019-05-22

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

2019年ARVO：Aflibercept能够长期改善黄斑变性的临床症状

2019-05-07

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Ophthalmol Ther：黄斑毛细血管扩张症2型的治疗综述

2019-05-02

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

NEJM：羟氯喹相关的牛眼黄斑病变-病例报道

2019-04-26

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

人工智能识别出7个潜力药物，治疗老年性黄斑变性

2019-04-18

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

DIABETOLOGIA：抗富马酸酶抗体促进糖尿病性黄斑水肿中感光细胞内外节段的脱落

2019-04-05

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

罗氏和基因泰克启动3期临床试验：评价双特异性抗体faricimab在湿性老年性黄斑变性中的潜力

2019-03-13

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Clin Exp Optom：新生血管年龄相关性黄斑变性患者眼内阿米替普治疗及其对脉络膜厚度的影响

2019-03-02

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

Klin Monbl Augenheilkd：阿柏西普对视网膜中央静脉阻塞后黄斑水肿的治疗效果

2019-02-27

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

英国医生开创基因疗法治疗老年性黄斑病变

2019-02-25

muzishouyi (审核中...)

前往app查看评论内容

#黄斑#

英国实施全球首例老年黄斑变性基因疗法手术

2019-02-24

科室
- - 订阅+
  - 更多科室
工具
服务